MXPA03005567A - Usos novedosos de antogonistas no peptidicos del receptor de bombesina, para el tratamiento de ansiedad y trastornos de panico. - Google Patents
Usos novedosos de antogonistas no peptidicos del receptor de bombesina, para el tratamiento de ansiedad y trastornos de panico.Info
- Publication number
- MXPA03005567A MXPA03005567A MXPA03005567A MXPA03005567A MXPA03005567A MX PA03005567 A MXPA03005567 A MX PA03005567A MX PA03005567 A MXPA03005567 A MX PA03005567A MX PA03005567 A MXPA03005567 A MX PA03005567A MX PA03005567 A MXPA03005567 A MX PA03005567A
- Authority
- MX
- Mexico
- Prior art keywords
- receptor antagonists
- treating anxiety
- panic disorders
- bombesin receptor
- novel uses
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0402—Organic compounds carboxylic acid carriers, fatty acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0404—Lipids, e.g. triglycerides; Polycationic carriers
- A61K51/0406—Amines, polyamines, e.g. spermine, spermidine, amino acids, (bis)guanidines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0446—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0455—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0459—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/GB2000/004915 WO2002049644A1 (en) | 2000-12-20 | 2000-12-20 | Novel uses of non-peptide bombesin receptor antagonists for treating anxiety and panic disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA03005567A true MXPA03005567A (es) | 2003-10-06 |
Family
ID=9886720
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA03005567A MXPA03005567A (es) | 2000-12-20 | 2000-12-20 | Usos novedosos de antogonistas no peptidicos del receptor de bombesina, para el tratamiento de ansiedad y trastornos de panico. |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP1343498A1 (es) |
| KR (1) | KR20040007425A (es) |
| CN (1) | CN1461217A (es) |
| AU (1) | AU2001223816A1 (es) |
| BR (1) | BR0017393A (es) |
| CA (1) | CA2432066A1 (es) |
| HU (1) | HUP0302496A2 (es) |
| IL (1) | IL155773A0 (es) |
| MX (1) | MXPA03005567A (es) |
| PL (1) | PL362254A1 (es) |
| WO (1) | WO2002049644A1 (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0403578D0 (en) * | 2004-02-18 | 2004-03-24 | Biofocus Discovery Ltd | Compounds which interact with the G-protein coupled receptor family |
| JPWO2006115135A1 (ja) | 2005-04-21 | 2008-12-18 | アステラス製薬株式会社 | 過敏性腸症候群治療剤 |
| EP2100900A1 (en) * | 2008-03-07 | 2009-09-16 | Universitätsspital Basel | Bombesin analog peptide antagonist conjugates |
| CN103463017B (zh) * | 2013-09-23 | 2015-11-25 | 李淑兰 | Lycojaponicumin B在制备治疗胰腺癌药物中的应用 |
| CN113164552A (zh) * | 2018-10-04 | 2021-07-23 | 新泽西州立罗格斯大学 | 使用神经介素肽减少2型细胞因子介导的炎症的方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ333038A (en) * | 1996-08-22 | 2000-10-27 | Warner Lambert Co | Non-peptide bombesin receptor antagonists |
-
2000
- 2000-12-20 WO PCT/GB2000/004915 patent/WO2002049644A1/en not_active Application Discontinuation
- 2000-12-20 AU AU2001223816A patent/AU2001223816A1/en not_active Abandoned
- 2000-12-20 EP EP00987567A patent/EP1343498A1/en not_active Withdrawn
- 2000-12-20 IL IL15577300A patent/IL155773A0/xx unknown
- 2000-12-20 KR KR10-2003-7008211A patent/KR20040007425A/ko not_active Application Discontinuation
- 2000-12-20 PL PL36225400A patent/PL362254A1/xx not_active Application Discontinuation
- 2000-12-20 HU HU0302496A patent/HUP0302496A2/hu unknown
- 2000-12-20 BR BR0017393-2A patent/BR0017393A/pt not_active IP Right Cessation
- 2000-12-20 CN CN00820082A patent/CN1461217A/zh active Pending
- 2000-12-20 MX MXPA03005567A patent/MXPA03005567A/es unknown
- 2000-12-20 CA CA002432066A patent/CA2432066A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU2001223816A1 (en) | 2002-07-01 |
| BR0017393A (pt) | 2004-02-03 |
| EP1343498A1 (en) | 2003-09-17 |
| KR20040007425A (ko) | 2004-01-24 |
| IL155773A0 (en) | 2003-12-23 |
| CN1461217A (zh) | 2003-12-10 |
| WO2002049644A1 (en) | 2002-06-27 |
| PL362254A1 (en) | 2004-10-18 |
| HUP0302496A2 (hu) | 2003-12-29 |
| CA2432066A1 (en) | 2002-06-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA03000923A (es) | Compuestos de carboxamida y su uso como antagonistas de un receptor 11cby humano. | |
| IL152775A0 (en) | Il-8 receptor antagonists | |
| IL152700A0 (en) | Substituted 1-aminoalkyl-lactams and their use as muscarinc receptor antagonists | |
| DZ3309A1 (en) | Il-8 receptor antagonists | |
| AU4560601A (en) | Il-8 receptor antagonists | |
| IL162475A0 (en) | Method of treating ophthalmic disorders with epoxy-steroidal aldosterone receptor antagonists | |
| EP1274415A4 (en) | IL-8 RECEPTOR ANTAGONISTS | |
| MXPA03005567A (es) | Usos novedosos de antogonistas no peptidicos del receptor de bombesina, para el tratamiento de ansiedad y trastornos de panico. | |
| GB0028104D0 (en) | Bombesin receptor antagonists | |
| AP2002002599A0 (en) | Il-8 receptor antagonists | |
| EP1265905A4 (en) | IL-2 RECEPTOR ANTAGONISTS | |
| MXPA03004190A (es) | Tratamiento de trastornos de ansiedad. | |
| GB0028146D0 (en) | Bombesin receptor antagonists | |
| EP1274413A4 (en) | IL-8 RECEPTOR ANTAGONISTS | |
| PL366034A1 (en) | Il-8 receptor antagonists | |
| EP1274428A4 (en) | INTERLEUKIN-8 (IL-8) RECEPTOR ANTAGONISTS | |
| ZA200403530B (en) | Chemokine receptor antagonists and methods of use thereof. | |
| IL157102A0 (en) | Use of gal3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods | |
| EP1261329A4 (en) | IL-8 RECEPTOR ANTAGONISTS | |
| AU2002359706A1 (en) | Neuropeptide y5 receptor antagonists for treating depression, anxiety and dementia | |
| IL151434A0 (en) | Il-8 receptor antagonists | |
| MXPA03004249A (es) | Nuevos usos de combinaciones selectivas antagonistas del receptor de dopamina d2 y agonistas del receptor de 5-ht1a. | |
| PL352222A1 (en) | Antagonists of the il-8 receptor |